In this scientific poster, we demonstrate the development of a novel synthetic gene promoter designed for CHO cells. Available as part of the GSquad® Pro vector system, the promoter demonstrates desirable bioproduction characteristics compared to the CMV promoter - higher titers, increased product quality, and long-term expression stability.
You may also be interested in:
Expression Technologies
Mammalian
Bispecific Antibody
Difficult to Express Proteins
Fabs, Fusion, Scaffold and other Recombinant Proteins
Monoclonal Antibody
Cell Line Development
Early De-risking & Optimization
Author(s):
Yusuf Johari, Ph.D.
Senior Principal Scientist, R&D
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.
Latest briefing from the Knowledge Center
Poster
Designing a Plug-and-Play System to Produce Engineered Extracellular Vesicles
Extracellular vesicles (EVs), including exosomes, are being studied extensively and have emerged as...
Poster
Plasmid Engineering and Process Development to Improve Self-Complementary AAV Productivity
Self-complementary AAV (scAAV) vectors were developed by mutating one of the ITRs to form...
Poster
Development of high-performing stable producer cell lines for therapeutic AAV vector manufacturing
Attributed to their safety profiles and transduction efficiencies, recombinant Adeno-associated...
Poster
Large-Scale High Titer Lentiviral Production Using Lonza's Suspension Transient Transfection...
Lentivirus vector (LVV) is a major player in cell and gene therapies. It efficiently transduces both...
Poster
Novel synthetic production phase promoter for enhanced titre, product quality and expression...
In this scientific poster, we demonstrate the development of a novel synthetic gene promoter...
Dolphin expansion rendering
Interview
Q&A on large-scale commercial expansion at Lonza's Stein facility
Are you a biopharmaceutical or biotech professional looking to stay ahead in the industry? Download...
Technical/Service brief
Novel synthetic fusion promoter for improved GS-CHO expression of biotherapeutics
Historically, advancements in CHO-based recombinant protein production have been driven...
Bend inhalation images
White paper
Navigating the development of dry powder for inhalation
Interest in pulmonary/nasal routes for local delivery has significantly increased over the last...
White paper
Innovations in linking rational design and material-sparing strategies for enabled intermediates and...
Did you catch our insightful webinar on Linking rational design and material-sparing strategies for...
Presentation (on-demand)
Challenging your AAV productivity and packaging efficiencies through a validated platform
AAV transient and stable cell line platforms represent a leap into next-generation technologies that...
Capsule services
Webinar (on-demand)
End-to-end regulatory CDMO solutions: development, manufacturing, and approval
Navigating the journey from drug development to market can feel like a maze, with each step...
techs looking at screen - ACHIEV
White paper
Seamless commercial tech transfers in OSD manufacturing
Remember our insightful webinar on Commercial tech transfers in OSD manufacturing? If you missed it,...